Adult Arm of DZL All Age Asthma Cohort (ALLIANCE)
NCT02419274 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2023-10-12
Summary
Deep Phenotyping of adult asthma patients:
* severity from mild to severe
* both atopic and non-atopic
* both childhood and adult onset
* both smokers and non-smokers
* corresponding pediatric cohort (Pediatric Arm of DZL All Age Asthma Cohort) with equivalent SOPs regarding collection of biomaterial and clinical data incl. lung function, further processing of biomaterial and further analyses
Conditions
Sponsors & Collaborators
-
German Center for Lung Research
collaborator OTHER -
Research Center Borstel
collaborator OTHER -
LungenClinic Grosshansdorf
lead OTHER
Principal Investigators
-
Klaus F Rabe, MD PhD · LungenClinic Grosshansdorf, Grosshansdorf, Germany
-
Susanne Krauss-Etschmann, PhD · Research Center Borstel, Borstel, Germany
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-03-31
- Primary Completion
- 2025-12-31
- Completion
- 2030-12-31
Countries
- Germany
Study Locations
More Related Trials
-
Cohort Analysis of Clinical and Biological Severe Childhood Asthma
NCT02114034 ·Status: ACTIVE_NOT_RECRUITING
-
Observational Study Regarding Adherence, Drug Use, Will to Take Part in Shared Decisioning in Asthma Outpatients
NCT00557141 ·Status: UNKNOWN
-
Longitudinal Phenotyping and Endotyping Study in Adult Patients With Mild, Moderate, or Severe Asthma
NCT07189806 ·Status: RECRUITING
-
Clinical Relevance of Small Airways Disease in Severe Asthma Patients Treated With Anti-InterLeukin-5 Therapy
NCT05706597 ·Status: UNKNOWN
-
Non-Eosinophilic Neutrophilic Asthma
NCT03479138 ·Status: COMPLETED
-
Glasgow Asthma and Allergy Study
NCT01618318 ·Status: COMPLETED
-
Seinäjoki Adult Asthma Study
NCT02733016 ·Status: COMPLETED
-
Asthma Control, Quality of Life and Emotional Feelings in a Real Life Setting
NCT02640742 ·Status: COMPLETED
-
Investigation to Identify Predictors of Response to a Treatment With Montelukast
NCT00721240 ·Status: COMPLETED ·Phase: PHASE4
-
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
NCT00576069 ·Status: RECRUITING
-
Dose Ranging Study Evaluating the Efficacy and Safety of GSK2190915 Administered Once Daily
NCT01147744 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II Study to Evaluate the Efficacy, Safety and Tolerability of AZD5069 in Patients With Uncontrolled Persistent Asthma.
NCT01704495 ·Status: COMPLETED ·Phase: PHASE2
-
Montelukast Asthmatic Smoker Study (0476-332)(COMPLETED)
NCT00284856 ·Status: COMPLETED ·Phase: PHASE3
-
Study of an Approved Drug in Patients With Asthma (0476-289)(COMPLETED)
NCT00092144 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of Airway Responsiveness and Treatment Efficacy in Asthmatics
NCT02574975 ·Status: UNKNOWN ·Phase: PHASE4
-
Ex Vivo Effect of Surfactant Protein D on Pulmonary Cells in Patients With Asthma and Pilot Study to Assess Local Inflammation Induced by Segmental Allergen Challenge by Magnetic Resonance Imaging
NCT01378624 ·Status: COMPLETED ·Phase: NA
-
Study With GW274150 In Patients With Mild Asthma
NCT00273013 ·Status: COMPLETED ·Phase: PHASE1
-
Launching an Asthma Initiative Designed to Improve Asthma Management and Outcomes
NCT02140671 ·Status: UNKNOWN
-
Functional Lung MRI for Early Treatment Response Assessment for Patients With Eosinophilic Asthma
NCT04512521 ·Status: UNKNOWN
-
Study of Magnitude and Prediction of Response to Omalizumab and Mepolizumab in Adult Severe Asthma.
NCT03476109 ·Status: UNKNOWN ·Phase: PHASE4
-
Phenotyping Circulating and Lung Resident Eosinophils in Severe Asthma (P-CLESA)
NCT04463836 ·Status: UNKNOWN
-
Cross-sectional Study for Identification and Description of Severe Asthma Patients
NCT02293265 ·Status: COMPLETED ·Phase: PHASE3
-
Ex Vivo Effect of Surfactant Protein D on Pulmonary Immune Cells Derived From Bronchoalveolar Lavage After Segmental Allergen Challenge in Patients With Asthma
NCT00771992 ·Status: COMPLETED ·Phase: NA
-
Asthma Control in Elderly Patients With Montelukast
NCT01147510 ·Status: COMPLETED ·Phase: PHASE4
-
Multidimensional Assessment of Dyspnea in Asthma
NCT04286906 ·Status: TERMINATED